Clinical Trials Browser

Neoplasms × palbociclib × Lymphoid × Clear all

NCT02693535 2026-05-29

TAPUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT00141297 2016-01-05

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Phase 1 Completed

74 enrolled 34 charts

Lymphoma, Non-Hodgkin, Neoplasms